Stryker PE Ratio 2006-2018 | SYK

Current and historical PE ratio for Stryker (SYK) from 2006 to 2018. The price to earnings or PE ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Stryker (SYK) as of March 31, 2018 is 25.92.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.003B $12.444B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $118.585B 18.35
Abbott Laboratories (ABT) United States $108.312B 23.67
Boston Scientific (BSX) United States $45.741B 25.50
Baxter (BAX) United States $39.631B 28.36
Zimmer Biomet Holdings (ZBH) United States $22.894B 14.42
ResMed (RMD) United States $15.554B 32.53
Smith & Nephew SNATS (SNN) United Kingdom $15.552B 0.00
Perrigo (PRGO) Ireland $10.390B 14.57
Bio-Rad Laboratories (BIO) United States $8.957B 72.24
Hill-Rom Holdings (HRC) United States $6.056B 21.76
ICU Medical (ICUI) United States $6.049B 56.28
Canopy Growth (CGC) Canada $5.965B 0.00
Agios Pharmaceuticals (AGIO) United States $5.185B 0.00
Insulet (PODD) United States $5.051B 0.00
Haemonetics (HAE) United States $4.937B 50.84
Hutchison China MediTech (HCM) China $4.212B 0.00
Neogen (NEOG) United States $4.163B 71.90
GW Pharmaceuticals (GWPH) United Kingdom $4.110B 0.00
National Vision Holdings (EYE) United States $3.029B 0.00
NuVasive (NUVA) United States $2.707B 27.36
Quidel (QDEL) United States $2.607B 114.10
Phibro Animal Health (PAHC) United States $1.948B 28.92
Abaxis,Inc (ABAX) United States $1.905B 64.06
NxStage Medical (NXTM) United States $1.865B 0.00
VAREX IMAGING (VREX) United States $1.410B 21.73
Eagle Pharmaceuticals (EGRX) United States $1.184B 33.12
Cardiovascular Systems (CSII) United States $1.157B 0.00
Orthofix (OFIX) $1.081B 32.93
Owens & Minor (OMI) United States $1.073B 10.79
AtriCure (ATRC) United States $1.008B 0.00
OraSure Technologies (OSUR) United States $0.994B 60.28
TG Therapeutics (TGTX) United States $0.967B 0.00
Omeros (OMER) United States $0.966B 0.00
Cerus (CERS) United States $0.956B 0.00
MacroGenics (MGNX) United States $0.912B 0.00
Surmodics (SRDX) United States $0.773B 132.50
LeMaitre Vascular (LMAT) United States $0.702B 41.32
Meridian Bioscience (VIVO) United States $0.665B 23.43
PetIQ (PETQ) United States $0.637B 0.00
Evolus (EOLS) United States $0.594B 0.00
Insys Therapeutics (INSY) United States $0.555B 0.00
Lantheus Holdings (LNTH) United States $0.536B 14.00
Surface Oncology (SURF) United States $0.423B 0.00
NanoString Technologies (NSTG) United States $0.389B 0.00
Utah Medical Products (UTMD) United States $0.378B 25.02
Cytosorbents (CTSO) United States $0.365B 0.00
Quanterix (QTRX) United States $0.324B 0.00
BioLife Solutions (BLFS) United States $0.296B 0.00
Chimerix (CMRX) United States $0.226B 0.00
Rockwell Medical (RMTI) United States $0.218B 0.00
Fonar (FONR) United States $0.173B 10.52
Bovie Medical (BVX) United States $0.169B 0.00
Chembio Diagnostics (CEMI) United States $0.158B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.135B 0.00
Female Health (VERU) United States $0.112B 0.00
Trinity Biotech (TRIB) Ireland $0.106B 31.75
Oramed Pharmaceuticals (ORMP) Israel $0.099B 0.00
Neurotrope (NTRP) United States $0.090B 0.00
United-Guardian (UG) United States $0.090B 20.97
InfuSystems Holdings (INFU) United States $0.077B 0.00
CAS Medical Systems (CASM) United States $0.057B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.046B 0.00
Capricor Therapeutics (CAPR) United States $0.041B 0.00
Valeritas Holdings (VLRX) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Akers Biosciences Inc (AKER) United States $0.031B 0.00
Myomo (MYO) United States $0.028B 0.00
Senestech (SNES) United States $0.027B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.010B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00